RAPA-Keloid Study of Keloid Regression

NCT04049552 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

4

Enrollment

OTHER

Sponsor class

Conditions

Keloid

Interventions

DRUG: Rapamycin 8% Ointment
DRUG: Placebo

Sponsor

The University of Texas Health Science Center at San Antonio